Paydirt
JA
Insider

John Aballi

President and CEO

John Aballi (President and CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Exagen Inc. (XGN). The largest single filing was $376K of XGN (31,787 sh × $11.82, as filed), executed Oct 16 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$376K
shares × price, as filed
Last traded
Oct 16 2025
Filed Oct 20 2025

Median ADV $2.3M across their filed names

Open performance
Volume by month
$376K$188K$0Oct 2024Apr 2025Oct 2025Apr 2026Oct 2025 · sells $376K
Buys $0 Sells $376K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
XGN Exagen Inc. XGN · 0 buys · 1 sell 1 filing
Recent filings
XGNSALE Exagen Inc. View filing → $376K
31,787 sh × $11.82
Exec Oct 16 2025
Filed Oct 20 2025 · 5:30 PM ET